| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 09/09/2009 | CN101524403A Ear applied liquid for neck-shoulder pain |
| 09/09/2009 | CN101524234A Pillow with function of treating cervical spondylosis |
| 09/09/2009 | CN101524232A Concave medicine pillow |
| 09/09/2009 | CN101524223A Production method of silk quilt for preventing and treating rheumatoid arthritis |
| 09/09/2009 | CN100537571C Imidazo[1,2-a]pyrazin-8-ylamines, method of making and method of use thereof |
| 09/09/2009 | CN100537520C N-bridged selective androgen receptor modulators and methods of use thereof |
| 09/09/2009 | CN100536919C Interferon antagon and usage of Flt3L antagon |
| 09/09/2009 | CN100536839C Urea derivatives as integrin alpha 4 antagonists |
| 09/08/2009 | US7585880 Phenylpropanoic acid derivatives |
| 09/08/2009 | US7585867 Substituted thiazolo[4,5-d]pyrimidin-2(3H)-one |
| 09/08/2009 | US7585860 Substituted oxazolidinones and their use in the field of blood coagulation |
| 09/08/2009 | US7585841 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase Src |
| 09/08/2009 | US7585835 GASP1: a follistatin domain containing protein |
| 09/08/2009 | US7585637 Estrogen related receptor, ERRα, a regulator of bone formation |
| 09/08/2009 | US7585507 Nucleic acid molecules and polypeptides for immune modulation |
| 09/08/2009 | CA2468833C (20s)-1.alpha.-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses |
| 09/08/2009 | CA2442210C Aryl oxime-piperazines useful as ccr5 antagonists |
| 09/08/2009 | CA2387351C Indole derivatives as tyrosine kinase inhibitors |
| 09/08/2009 | CA2290745C Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 09/03/2009 | WO2009107767A1 Novel bicyclic pyrimidine derivative having antagonistic activity on h4 receptor |
| 09/03/2009 | WO2009106752A2 Derivatives of 2-heteroaroyl-imidazol[1,2-a]pyridine, preparation thereof and therapeutic application thereof |
| 09/03/2009 | WO2009106751A2 Derivatives of n-heterocyclic-6-heterocyclic-imidazo[l,2- a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/03/2009 | WO2009106750A2 Derivatives of 6-heterocyclic-imidazo[l,2-a]pyrroine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/03/2009 | WO2009106749A2 Derivatives of n-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/03/2009 | WO2009106748A2 Derivatives of n-phenyl-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/03/2009 | WO2009106708A2 Azetidine derivatives, their preparation and their application in therapy |
| 09/03/2009 | WO2009106531A1 Pyrrolopyrimidinecarboxamides |
| 09/03/2009 | WO2009106339A1 A method for restoring bmp-receptor signaling in a cell |
| 09/03/2009 | WO2009106125A1 Polyphenols for the treatment of cartilage disorders |
| 09/03/2009 | WO2009105934A1 Monoclonal antibody anti-human rankl |
| 09/03/2009 | WO2009087379A3 Tetrahydrofuro (3, 2 -b) pyrrol- 3 -one derivatives as inhibitors of cysteine proteinases |
| 09/03/2009 | WO2009030492A3 Functionalized nanoparticles for the inhibition of selectin-mediated cell adhesion |
| 09/03/2009 | WO2008103690A3 Prevention and treatment for osteonecrosis and osteoradionecrosis of the jaw using pdgf and a bone matrix |
| 09/03/2009 | US20090221695 Chroman Derivatives as Estrogenic Compounds |
| 09/03/2009 | US20090221686 Modulation of the Transcription of Pro-Inflammatory Gene Products |
| 09/03/2009 | US20090221632 Bicyclo-Pyrazoles and Pharmaceutical Compositions Comprising Them |
| 09/03/2009 | US20090221602 Processes for preparing substituted pyrimidines |
| 09/03/2009 | US20090221566 Inhibitors of phosphodiesterase type-iv |
| 09/03/2009 | US20090221543 New corticosteroids |
| 09/03/2009 | US20090221503 Use of rapamycin and rapamycin derivatives for the treatment of bone loss |
| 09/03/2009 | US20090220586 Proteomimetic compounds as inhibitors of the interaction of nuclear receptor with coactivator peptides |
| 09/03/2009 | US20090220562 Osteogenic and anti-adipogenic oxysterols |
| 09/03/2009 | DE102008012005A1 Chinese herbal recipe useful in diseases of the locomotor system in human beings and animals, where the diseases are vertebral complaints, rheumatoid disease and joint complaints |
| 09/03/2009 | DE102008011868A1 Combined agent, useful e.g. to treat bone diseases, which are conditioned by increased osteoclastic activity, and osteoporosis, comprises two separate agents such as carboanhydrase-inhibitor and/or H(+)-ATPase inhibitor and parathormone |
| 09/03/2009 | CA2711733A1 Pyrrolopyrimidinecarboxamides |
| 09/03/2009 | CA2710962A1 Derivatives of 2-heteroaroyl-imidazol[1,2-a]pyridine, preparation thereef and therapeutic application thereof |
| 09/03/2009 | CA2710947A1 Derivatives of 6-heterocyclic-imidazo[1,2-a]pyrroine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/03/2009 | CA2710943A1 Derivatives of n-phenyl-imidazo[1,2-.alpha.]pyridine-2-carboxamides, preon thereof and therapeutic application thereof |
| 09/03/2009 | CA2710860A1 Derivatives of n-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/03/2009 | CA2710794A1 Derivatives of n-heterocyclic-6-heterocyclic-imidazo[l,2-.alpha.]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/03/2009 | CA2709863A1 Azetidine derivatives, their preparation and their application in therapy |
| 09/02/2009 | EP2095824A1 A method for restoring BMP-receptor signaling in a cell |
| 09/02/2009 | EP2094708A2 A pyrrolopyrazin as syk-kinase inhibitor |
| 09/02/2009 | EP2094289A1 Conjoint therapy for treating fibrotic diseases |
| 09/02/2009 | EP2094280A1 Pharmaceutical agent having long-lasting effect of treating arthritic disorders |
| 09/02/2009 | EP2094255A1 Modulators of beta-2-adrenergic receptor for treating conditions characterized by disorganized vasculature |
| 09/02/2009 | EP1470137B1 Edg receptor agonists |
| 09/02/2009 | EP1466925B1 Antibodies against fibroblast growth factor 23 |
| 09/02/2009 | EP1458392B1 Acridones as inhibitors of impdh enzyme |
| 09/02/2009 | EP1392349B1 Use of angiotensinogen and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions |
| 09/02/2009 | EP1276483B1 Compositions and methods for treating amyloidosis using sulphonate derivatives |
| 09/02/2009 | CN101519404A 15-cyclothiaketone derivative, preparation method and application thereof |
| 09/02/2009 | CN101519393A Novel method for preparing Scopoletin |
| 09/02/2009 | CN101518654A Method for synthesizing novel preparation capable of carrying glucocorticoid to be used as inflammation targeted drug |
| 09/02/2009 | CN101518650A Combination of a DPP IV inhibitor and a cardiovascular compound |
| 09/02/2009 | CN101518648A Soluble receptor BR43x2 and methods of using |
| 09/02/2009 | CN101518643A Antiphlogistic and analgesic ointment |
| 09/02/2009 | CN101518631A Medicament for treating rheumatoid arthritis |
| 09/02/2009 | CN101518630A Anti-gout traditional Chinese medical composition and preparation method thereof |
| 09/02/2009 | CN101518627A Drug for treating broken bones by fast reunion of muscles and bones |
| 09/02/2009 | CN101518611A Traditional Chinese medicine for treating bone tumor |
| 09/02/2009 | CN101518610A Orthopedic persistent ailment treating medicament and preparation method thereof |
| 09/02/2009 | CN101518603A Traditional Chinese medical composition used for treating prostatic hyperplasia and preparation method thereof |
| 09/02/2009 | CN101518599A Slow-release patch with daphne giraldii bark extract, and preparation method thereof |
| 09/02/2009 | CN101518588A Traditional Chinese medicine for treating diabetic arthrodynia |
| 09/02/2009 | CN101518582A Traditional Chinese medicine cream for treating bone fracture diseases and preparation method thereof |
| 09/02/2009 | CN101518573A External pulvis for treating rheumatoid arthritis |
| 09/02/2009 | CN101518521A New medical application of cedrol |
| 09/02/2009 | CN101518520A Framework-type transdermal patch with dextro ketoprofen accumulated in subcutaneous deep tissues |
| 09/02/2009 | CN100534991C Heterocyclic inhibitors of ERK 2 and uses thereof |
| 09/02/2009 | CN100534981C 2-propylidene-19-nor-vitamin d compounds |
| 09/02/2009 | CN100534479C Aerosol for treating knochs and falls and preparation method thereof |
| 09/02/2009 | CN100534438C Difructose anhydride-containing composition and use thereof |
| 09/02/2009 | CN100534436C Polynucleotide therapy |
| 09/01/2009 | US7582756 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors |
| 09/01/2009 | US7582666 Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1,3-oxazolines and their use as anticoagulant and antithrombotics |
| 09/01/2009 | US7582660 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 09/01/2009 | US7582658 Bicyclic compound |
| 09/01/2009 | US7582657 Vanilloid receptor ligands and their use in treatments |
| 09/01/2009 | US7582648 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
| 09/01/2009 | US7582644 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 09/01/2009 | US7582640 3-[[5-Ethyl-6-[4-(1,2,3,4-tetrahydro-1,8-naphthyridin-7-yl)-1-piperidinyl]-4-pyrimidinyl]amino]-N-[(phenylmethoxy)carbonyl]alanine; osteoporois; restenosis; arteriosclerosis; cell adhesion/bone bioresorption inhibiters; cardiovascular disorders; antitumor agents; anticarcinogenic agents; bone disorders |
| 09/01/2009 | US7582317 Food supplements comprising, as a health component, sargahydroquinoic acid or derivative thereof |
| 09/01/2009 | US7582313 Methods of organ regeneration using Hox 11-expressing pluripotent cells |
| 09/01/2009 | CA2210812C T-cell affecting peptides |
| 08/27/2009 | WO2009104913A2 Composition comprising an extract of mixed herbs with lonicera japonica thunb and anemarrhena asphodeloides bunge for preventing and treating arthritic diseases |
| 08/27/2009 | WO2009104807A1 Composition for modulating stem cell growth with prostaglandins |
| 08/27/2009 | WO2009104388A1 Prophylactic/therapeutic agent for collagenosis |
| 08/27/2009 | WO2009104248A1 Adrenomedullin production enhancer |
| 08/27/2009 | WO2009103123A1 Dendrimeric enzyme inhibitors |